Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 CSF1R [3] Ras signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Transcriptional misregulation in cancer D08552 Sunitinib [2] 28, 34
2 CSF1R [3] Ras signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Transcriptional misregulation in cancer D11270 Pexidartinib [1] 34
3 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D01977 Gefitinib [1] 75
4 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D03455 Cetuximab [2] 51, 86
5 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D07907 Erlotinib [1] 94
6 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D08108 Lapatinib [3] 34, 74, 75
7 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D08950 Neratinib [1] 34
8 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D11251 Icotinib [1] 34
9 EGFR [4] Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis D11772 Tesevatinib [1] 67
10 EPHA2 [1] Ras signaling pathway D03658 Dasatinib [2] 51, 85
11 EPHA2 [1] Ras signaling pathway D06414 Dasatinib [2] 51, 85
12 FGFR1 [4] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton D10481 Nintedanib [5] 51, 85, 89, 227, 228
13 FGFR1 [4] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton D11589 Infigratinib [1] 276
14 FGFR3 [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib [5] 51, 85, 89, 227, 228
15 FGFR3 [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib [1] 276
16 FGFR2 [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D05338 Palifermin [5] 13, 36, 38, 39, 65
17 FGFR2 [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D10481 Nintedanib [5] 51, 85, 89, 227, 228
18 FGFR2 [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton D11589 Infigratinib [1] 276
19 FLT1 [3] Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D03218 Axitinib [1] 34
20 FLT1 [3] Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08552 Sunitinib [2] 28, 34
21 FLT1 [3] Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D08881 Cediranib [1] 34
22 FLT1 [3] Ras signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis D10481 Nintedanib [5] 51, 85, 89, 227, 228
23 FLT3 [2] Ras signaling pathway, Transcriptional misregulation in cancer D08524 Sorafenib [2] 34, 86
24 FLT3 [2] Ras signaling pathway, Transcriptional misregulation in cancer D08552 Sunitinib [2] 28, 34
25 FLT3 [2] Ras signaling pathway, Transcriptional misregulation in cancer D11270 Pexidartinib [1] 34
26 FLT4 [1] Ras signaling pathway D03218 Axitinib [1] 34
27 FLT4 [1] Ras signaling pathway D08524 Sorafenib [2] 34, 86
28 FLT4 [1] Ras signaling pathway D08552 Sunitinib [2] 28, 34
29 FLT4 [1] Ras signaling pathway D08881 Cediranib [1] 34
30 FLT4 [1] Ras signaling pathway D10481 Nintedanib [5] 51, 85, 89, 227, 228
31 FLT4 [1] Ras signaling pathway D11772 Tesevatinib [1] 67
32 ABL1 [2] Ras signaling pathway, Viral myocarditis D03252 Bosutinib [2] 2, 67
33 ABL1 [2] Ras signaling pathway, Viral myocarditis D03658 Dasatinib [2] 51, 85
34 ABL1 [2] Ras signaling pathway, Viral myocarditis D06414 Dasatinib [2] 51, 85
35 ABL1 [2] Ras signaling pathway, Viral myocarditis D08066 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
36 ABL1 [2] Ras signaling pathway, Viral myocarditis D08953 Nilotinib [5] 6, 8, 34, 51, 86
37 ABL1 [2] Ras signaling pathway, Viral myocarditis D09664 Saracatinib [3] 6, 89, 272
38 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
39 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
40 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D07058 Acamprosate [2] 6, 206
41 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D07283 Esketamine [3] 2, 4, 70
42 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D07441 Amantadine [4] 6, 8, 13, 127
43 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
44 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D08174 Memantine [8] 2, 6, 8, 13, 49, 127, 205, 206
45 GRIN1 [2] Ras signaling pathway, Spinocerebellar ataxia D09917 Latrepirdine [1] 8
46 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
47 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
48 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07058 Acamprosate [2] 6, 206
49 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07283 Esketamine [3] 2, 4, 70
50 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07441 Amantadine [4] 6, 8, 13, 127
51 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
52 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08174 Memantine [8] 2, 6, 8, 13, 49, 127, 205, 206
53 GRIN2A [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D09917 Latrepirdine [1] 8
54 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D00775 Riluzole [9] 2, 3, 5, 8, 13, 17, 18, 203, 206
55 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D03742 Dextromethorphan [11] 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
56 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07058 Acamprosate [2] 6, 206
57 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07283 Esketamine [3] 2, 4, 70
58 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D07441 Amantadine [4] 6, 8, 13, 127
59 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08098 Ketamine [8] 2, 4, 6, 13, 70, 113, 156, 215
60 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D08174 Memantine [8] 2, 6, 8, 13, 49, 127, 205, 206
61 GRIN2B [3] Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus D09917 Latrepirdine [1] 8
62 IGF1R [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D03297 Mecasermin [6] 65, 78, 96, 168, 265, 299
63 IGF1R [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D09680 Teprotumumab [1] 51
64 IGF1R [3] Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer D09925 Linsitinib [1] 232
65 INSR [3] Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03230 Insulin human [2] 96, 156
66 INSR [3] Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D03250 Insulin glargine [1] 299
67 INSR [3] Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus D04539 Insulin detemir [1] 299
68 KDR [2] Ras signaling pathway, VEGF signaling pathway D03218 Axitinib [1] 34
69 KDR [2] Ras signaling pathway, VEGF signaling pathway D08524 Sorafenib [2] 34, 86
70 KDR [2] Ras signaling pathway, VEGF signaling pathway D08552 Sunitinib [2] 28, 34
71 KDR [2] Ras signaling pathway, VEGF signaling pathway D08881 Cediranib [1] 34
72 KDR [2] Ras signaling pathway, VEGF signaling pathway D10062 Cabozantinib [1] 34
73 KDR [2] Ras signaling pathway, VEGF signaling pathway D10481 Nintedanib [5] 51, 85, 89, 227, 228
74 KDR [2] Ras signaling pathway, VEGF signaling pathway D11772 Tesevatinib [1] 67
75 KIT [1] Ras signaling pathway D03658 Dasatinib [2] 51, 85
76 KIT [1] Ras signaling pathway D06414 Dasatinib [2] 51, 85
77 KIT [1] Ras signaling pathway D08066 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
78 KIT [1] Ras signaling pathway D08524 Sorafenib [2] 34, 86
79 KIT [1] Ras signaling pathway D08552 Sunitinib [2] 28, 34
80 KIT [1] Ras signaling pathway D08953 Nilotinib [5] 6, 8, 34, 51, 86
81 KIT [1] Ras signaling pathway D10229 Masitinib [6] 2, 5, 6, 13, 46, 96
82 KIT [1] Ras signaling pathway D11270 Pexidartinib [1] 34
83 MET [3] Ras signaling pathway, Transcriptional misregulation in cancer, Renal cell carcinoma D10062 Cabozantinib [1] 34
84 NFKB1 [17] Ras signaling pathway, Sphingolipid signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer D01146 Iguratimod [5] 46, 51, 53, 271, 300
85 NGF [1] Ras signaling pathway D09387 Tanezumab [2] 226, 298
86 NGFR [3] Virion - Lyssavirus, Ras signaling pathway, Transcriptional misregulation in cancer D11028 Cenegermin [2] 53, 90
87 PDGFRA [2] Ras signaling pathway, Regulation of actin cytoskeleton D08066 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
88 PDGFRA [2] Ras signaling pathway, Regulation of actin cytoskeleton D08552 Sunitinib [2] 28, 34
89 PDGFRA [2] Ras signaling pathway, Regulation of actin cytoskeleton D08953 Nilotinib [5] 6, 8, 34, 51, 86
90 PDGFRA [2] Ras signaling pathway, Regulation of actin cytoskeleton D10481 Nintedanib [5] 51, 85, 89, 227, 228
91 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D03658 Dasatinib [2] 51, 85
92 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D06414 Dasatinib [2] 51, 85
93 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D08524 Sorafenib [2] 34, 86
94 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D08552 Sunitinib [2] 28, 34
95 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D08953 Nilotinib [5] 6, 8, 34, 51, 86
96 PDGFRB [2] Ras signaling pathway, Regulation of actin cytoskeleton D10481 Nintedanib [5] 51, 85, 89, 227, 228
97 PGF [1] Ras signaling pathway D09574 Aflibercept [2] 90, 166
98 PIK3CA [19] Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11011 Alpelisib [1] 138
99 PIK3CA [19] Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib [2] 53, 65
100 PIK3CB [19] Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib [2] 53, 65
101 PIK3CD [19] Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11158 Leniolisib [2] 53, 65
102 PIK3CD [19] Ras signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer D11437 Parsaclisib [3] 35, 53, 61
103 PRKCB [11] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Salivary secretion, Spinocerebellar ataxia D11935 Enzastaurin [1] 168
104 MAP2K1 [16] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D09666 Selumetinib [1] 34
105 MAP2K1 [16] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
106 MAP2K1 [16] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10405 Cobimetinib [1] 280
107 MAP2K1 [16] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10604 Binimetinib [1] 34
108 MAP2K1 [16] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D11675 Mirdametinib [1] 34
109 MAP2K2 [14] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D09666 Selumetinib [1] 34
110 MAP2K2 [14] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
111 MAP2K2 [14] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10405 Cobimetinib [1] 280
112 MAP2K2 [14] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D10604 Binimetinib [1] 34
113 MAP2K2 [14] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer D11675 Mirdametinib [1] 34
114 RAF1 [13] Ras signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Renal cell carcinoma D08524 Sorafenib [2] 34, 86
115 RELA [17] Ras signaling pathway, Sphingolipid signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer D12181 Edasalonexent [1] 113
116 VEGFA [5] Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D05697 Ranibizumab [4] 34, 166, 227, 301
117 VEGFA [5] Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D06409 Bevacizumab [6] 13, 34, 85, 87, 227, 280
118 VEGFA [5] Ras signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis D09574 Aflibercept [2] 90, 166
119 VEGFB [2] Ras signaling pathway, Relaxin signaling pathway D09574 Aflibercept [2] 90, 166
120 FGF23 [2] Ras signaling pathway, Regulation of actin cytoskeleton D10913 Burosumab [1] 238